Related references
Note: Only part of the references are listed.Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen et al.
CANCER CELL (2021)
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
Sidse Ehmsen et al.
CANCER CELL (2021)
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
Samuel D. Stampfer et al.
LEUKEMIA (2021)
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis et al.
NATURE MEDICINE (2021)
Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
Sophie Steiner et al.
FRONTIERS IN IMMUNOLOGY (2021)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny et al.
CANCER CELL (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Polyfunctional T cell responses are a hallmark of HIV-2 infection
Melody G. Duvall et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)